SCHEMBL20189667

SCHEMBL20189667

C=CC[C@](C)(O)CNC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HMGCR P04035 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
ADRA1A P35348 1/20 0.33
MAPT P10636 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
FAAH O00519 1/20 0.31
CNR1 P21554 1/20 0.30
CNR2 P34972 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22028162 1.00 KMT2A (0.36) KMT2AMEN1SMN1; SMN2HMGCRCHRM1
SCHEMBL10815346 0.82 KMT2A (0.33) KMT2AMEN1SMN1; SMN2ALDH1A1TSHR
SCHEMBL2896474 0.82 L3MBTL1 (0.34) KMT2AMEN1SMN1; SMN2ALDH1A1TSHR
SCHEMBL26923970 0.79 HMGCR (0.34) KMT2AMEN1SMN1; SMN2HMGCRCHRM1
Bicarbonate SCHEMBL5505471 0.78 HMGCR (0.42) KMT2AMEN1SMN1; SMN2HMGCRCHRM1
SCHEMBL22080248 0.78 TDP1 (0.41) KMT2AMEN1SMN1; SMN2MAPTALDH1A1
SCHEMBL20501314 0.74 HMGCR (0.39) HMGCRCHRM1TBXA2RADRA1AALDH1A1
SCHEMBL16438125 0.74 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1AMAPT
SCHEMBL10974694 0.74 HMGCR (0.64) HMGCRCHRM1TBXA2RADRA1AMAPT
SCHEMBL2172457 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544968-A1 PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS Bristol-Myers Squibb Company (US) 2019-10-02 EP disclosed
WO-2018098413-A1 PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-31 WO disclosed